Page 735 - Fluid, Electrolyte, and Acid-Base Disorders in Small Animal Practice

Index 723

Docosahexaenoic acid (DHA), perioperative management of, 419 hypocalcemia due to, 171
for heart failure, 531 EHDP-didronel, for hypercalcemia, 158t for sepsis/septic shock, 574
DOCP, for hypoadrenocorticism, 508 Ehrlichiosis, transfusion-related, 591 Enteral nutrition, 623–646. See also Nutritional
Documentation, of fluid therapy, 344 Eicosapentaenoic acid (EPA), for heart failure, support
Dog erythrocyte antigen system, 589–590, 531 for acute pancreatitis, 447, 451
590b Electrocardiography. See also Arrhythmias appetite stimulation in, 627–628
Dopamine in fluid therapy monitoring, 393 arginine supplementation in, 638–639, 639b
for acute pancreatitis, 450 perioperative, 419 complications of
for heart failure, 529 Electrochemical equivalence, 7 gastrointestinal, 643–644
for oliguria, 549 Electrolytes. See also Solute(s) and specific mechanical, 643
for shock, 572–573, 573t electrolytes metabolic, 644
Doppler blood pressure measurement, 571 absorption and secretion of, 436–442 technical, 644
Dorsal pedal artery, catheterization of, 419 gastric, 436–437, 437f continuous infusion, 640–643
Drainage intestinal, 439–441, 440f, 442f diets in, 638–639, 639b, 640t
of ascitic fluid, 490–492, 491f, 528–529 regulation of, 442 drug-nutrient interactions in, 643
peritoneal, 412 in bile, 456t, 458 early initiation of, 623–626
Dressings, catheter, 372, 373 in body fluids, 2, 3f equipment suppliers for, 630b
Drinking, 17–20. See also Fluid intake in commercial fluids, 334, 338, 339, 340, feeding rate and volume in, 632b,
Drip rate, calculation of, 344 341 640, 643
Drug interactions daily requirements for, 333 gastric residual volume in, 640–641,
with intravenous fluids, 410 in enteral nutrition, 627 642–643
with nutrients in gastric juice, 276–277, 276f gastrostomy/jejunostomy, 634–635
in enteral nutrition, 643 in hemodialysate, 693–694 for acute pancreatitis, 451
in parenteral nutrition, 615 imbalances ofspecific disorders for diarrhea and vomiting, 447
Dyspnea, 298 in acute intoxications, 703–707 equipment for, 637b
Dysrhythmias. See Arrhythmias causes of, 334 percutaneous tube placement for
in cirrhosis, 469–470 endoscopic, 635, 636f
in heart failure, 526–527, 532–538 nonendoscopic, 635–638
E hemodialysis for, 702–703, 702f surgical tube placement for, 634–635,
Eccrine sweat glands, 17 in liver disease, 463f, 464–468, 464f, 465f, 635f, 636f
Echocardiography, in hemodialysis, 702–703, 467f, 469–470 intermittent bolus, 640–643, 641b
702f loss of, in fluid therapy, 395 nasoenteric, 629–631, 629b, 630f, 631f,
Eclampsia monitoring of, 393 632f
hypocalcemia and, 167–168, 174 in oral rehydration solutions, 446–447 nasojejunal, 636–638, 637f, 638f
hypophosphatemia and, 199 in pancreatic juice, 276, 276f nutrient requirements in, 626–627, 626f,
Edema in parenteral nutrition, 612, 613t, 614 627t
body organ, 396 transport of, 440–441, 440f, 442 orogastric, for neonates, 628–629, 629f
cerebral Electroneutrality, anion gap and, 13–14, 13f patient selection for, 623
in diabetic ketoacidosis, 501–502 Elizabethan collar, for nasoenteral feeding, 631, refeeding syndrome in, 644
hypernatremia and, 60 632f rescue protocol for, 641, 641f
hyponatremia and, 68 Embolism. See also Thrombosis tube flushing in, 643
perioperative management of, 412, 419 air, 377 Enteral route, in fluid therapy, 400
in congestive heart failure, 516, 519f transfusion-related, 594, 597 Enteral water, 546
in fluid therapy, 395, 485–486, 547 catheter, 377 Enteritis. See also Diarrhea; Vomiting
in heart failure, 516–518, 519f pulmonary, dextran prophylaxis for, 423 parvovirus, 444–445
diuretics for, 521–525 transfusion-related, 597 Enterocolitis, hypocalcemia and, 167
refractory, 531–532 Emergency cut-down procedure, 366, 368 Epinephrine, for shock, 573, 573t
renal function and, 519f, 521, 525 Enalapril, for heart failure, 529, 530, 531 Equivalent weight, 7–8
peripheral, perioperative management of, End-diastolic pressure, central venous pressure Ergocalciferol
411 and, 379, 380 for hypocalcemia, 175t, 177
pulmonary. See Pulmonary edema End-diastolic volume, central venous pressure toxicity of, 152–153
EDTA, for hypercalcemia, 158t, 162–163 and, 379, 380 Erythrocytes
Effective blood volume, 12 Endocrine disorders, perioperative for anemia of renal failure, 546
decreased management of, 415 bicarbonate production in, 289
causes of, 559, 560t Endogenous creatinine clearance, in polyuria/ chloride in, 80, 289
compensatory mechanisms for, 559–561 polydipsia, 70 in hypophosphatemia, 197–198
+
+
Effective circulating volume, 48, 559 Endometritis, hypercalcemia and, 156 Na ,K -ATPase in, 100–101
Effective osmolality, 8–9, 8f, 11, 46 Endotoxic shock, 464. See also Shock perioperative use of, 406, 428
Effective SID model, 324 fluid therapy for, 334 potassium in, 100–101, 100t
Efferent arterioles, glomerular filtration rate posttransfusion, 597 sodium in, 100t
and, 29, 29f Endotracheal intubation, 411 transfusion of, 586–587
Effusions Enemas Transfusion(s)
in fluid therapy, 397 for hepatic encephalopathy, 484–485, 484t for anemia, 406
in heart failure, 516–518, 519, 519f phosphate perioperative use of, 406,
refractory, 531–532 hyperphosphatemia due to, 203 407, 428
renal function and, 519f, 521, 525 hypocalcemia due to, 171 for shock, 565t, 569–570
perioperative management, 411, 412 Enrofloxacin Erythropoietin